Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
(NASDAQ: SILO) Delayed: 2.45 -0.05 (2%)
Previous Close $2.50    52 Week High $ 
Open $2.51    52 Week Low $ 
Day High $2.54    P/E N/A 
Day Low $2.37    EPS $ 
Volume 14,958       

(NASDAQ: SILO) Delayed: 2.45 -0.05 (2%)
Previous Close $2.50    52 Week High $ 
Open $2.51    52 Week Low $ 
Day High $2.54    P/E N/A 
Day Low $2.37    EPS $ 
Volume 14,958